IgG / Elsevier Inc. / ADP / Dura / Intracellular KG / /
Country
United States / /
Currency
AOA / / /
Event
Product Recall / Product Issues / /
Facility
Flemish Institute of Biotechnology / Beth Israel Medical Center / Women’s Hospital / Massachusetts Institute of Technology / /
IndustryTerm
energy-addicted cancers / media lacking pyruvate / biosynthetic machinery / putative bTrCP-binding site / energy / energy production / tumor systems / energy maintenance / phosphorylation site / cellular energy / low-energy conditions / gas chromatography/mass spectrometry / /
MarketIndex
set 195 / /
MedicalCondition
metastasis / several tumor / carcinoma / both ELT3 xenograft tumors / energy-addicted cancers / Pulmonary / mouse Tsc2+/ liver tumors / TSC2-expressing tumors / MS / breast cancer / prostate cancer DU145 / cancers / tumor / colon carcinoma DLD1 / cancer / human epithelial tumor / tumors / human cancer / carcinomas / leiomyoma cell line ELT3 expressing / tumor suppressors tuberous sclerosis / /
Organization
Harvard Medical School / Flemish Institute of Biotechnology / Vesalius Research Center / Women’s Hospital / Massachusetts Institute of Technology / Department of Medicine / NS NS / Department of Systems Biology / African Union / Beth Israel Medical Center / Department of Medicine / Brigham and Women / /
The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4 Alfred Csibi,1 Sarah-Maria Fendt,2,6 Chenggang Li,3,5 George Poulogiannis,4,5 Andrew Y. Choo,1 Douglas J. Chapski,1 Seung Min